Economic burden of rhinitis in managed care: A retrospective claims data analysis

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 1, 2008, Pages 23-29

  Dalal, Anand A ^a   Stanford, Richard ^a   Henry, Henk ^b   Borah, Bijan ^b  

^a GLAXOSMITHKLINE   (United States)

^b i3 Innovus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; MONTELUKAST;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHRONIC RHINITIS; COMORBIDITY; DATA ANALYSIS; DRUG COST; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE ORGANIZATION; OUTPATIENT CARE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SINUSITIS;

EID: 47349127622     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60830-7     Document Type: Article

References (29)

1. Dykewicz MS, Fineman S. Executive summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol. 1998;81:463-468.
2. National Center for Health Statistics, Centers for Disease Control and Prevention, US Department of Health and Human Services. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Available at: http://www.cdc.gov/nchs/about/otheract/icd9/ abticd9.htm. Accessed June 21, 2007.
3. Skoner DP. Complications of allergic rhinitis. J Allergy Clin Immunol. 2000;105(pt 2):S605-S609.
4. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol. 1997;99:S742-S749.
5. Kremer B. Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2004;4:171-176.
6. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 2007;28:3-9.
7. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994;94:182-188.
8. Meltzer EO, Nathan RA, Seiner JC, Storms W. Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol. 1997;99(suppl 2):S815-S819.
9. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg. 2004;130:617-629.
10. Nathan RA, Meltzer EO, Seiner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99(suppl 2):S808-S814.
11. Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. BMJ. 1987;294:279-283.
12. Åberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy. 1989;19:59-63.
13. Hopper JL, Jenkins MA, Carlin JB, Giles GG. Increase in the self-reported prevalence of asthma and hay fever in adults over the last generation: a matched parent-offspring study. Aust J Public Health. 1995;19:120-124.
14. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758-764.
15. Huurree TM, Aro HM, Jaakkola JJ. Incidence and prevalence of asthma and allergic rhinitis: a cohort study of Finnish adolescents. J Asthma. 2004;41:311-317.
16. Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics. 2004;22:345-361.
17. Virant FS. Allergic rhinitis. Immunol Allergy Clin North Am. 2000;20:265-282.
18. Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol. 1999;103:401-407.
19. Schoenwetter WF, Dupclay L Jr, Appajosyula S, et al. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin. 2004;20:305-317.
20. Duan A. Smear estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78:605-610.
21. Manning WG, Mullahy J. Estimating log models: to transform or not to transform. J Health Econ. 2001;20:461-494.
22. Corren J, Manning BE, Thompson SF, Hennessey S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case control study. J Allergy Clin Immunol. 2004;113:415-419.
23. Fuhlbrigge AL, Adams RJ. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr Opin Allergy Clin Immunol. 2003;3:29-32.
24. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy. 1994;73:35-39.
25. Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99(pt 1):22-27.
26. Mackowiak JI. The health and economic impact of rhinitis. Am J Manag Care. 1997;3(suppl II):S8-S18.
27. Baraniuk JM, Meltzer EO, Spector SL. Impact of allergic rhinitis and related airway disorders. J Respir Dis. 1996;17(suppl):511-523.
28. Storms W, Meltzer EO, Nathan RA, et al. The economic impact of allergic rhinitis. J Allergy Clin Immunol. 1997;99(suppl 2):S820-S824.
29. Law AW, Reed SD, Sundy J, et al. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2003;111:296-300.